Biora Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $32 | $318 | $542 | $0 |
Gross Profit | 32 | 208 | 437 | |
EBITDA | -16,227 | 7,218 | -1,279 | -13,125 |
EBIT | -16,338 | 7,108 | -1,384 | -13,344 |
Net Income | -18,402 | 6,465 | -4,189 | -15,413 |
Net Change In Cash | 32 | 318 | 542 | 0 |
Free Cash Flow | 31,951 | -11,132 | -12,511 | -13,811 |
Cash | 3,196 | 5,325 | 10,820 | 15,211 |
Basic Shares | 3,652 | 74,215,969 | 29,296 | 24,810 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $4 | $305 | $1,247 | $74,313 |
Gross Profit | -551 | -602 | -190 | -19,120 |
EBITDA | -114,054 | -37,353 | -164,567 | -190,129 |
EBIT | -114,609 | -38,260 | -166,004 | -195,188 |
Net Income | -124,115 | -48,830 | -178,521 | -192,528 |
Net Change In Cash | 4 | 305 | 1,247 | 74,313 |
Free Cash Flow | -48,602 | -65,209 | -168,341 | -170,688 |
Cash | 15,211 | 30,486 | 88,397 | 92,076 |
Basic Shares | 15,773 | 7,635 | 3,846 | 2,230 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$5.04 |
2024-06-30 | $0.18 |
2024-03-31 | -$0.14 |
2023-12-31 | -$0.62 |
